Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
32.4M
-
Shares change
-
-1.19M
-
Total reported value, excl. options
-
$130M
-
Value change
-
-$5.59M
-
Put/Call ratio
-
2.91
-
Number of buys
-
44
-
Number of sells
-
-25
-
Price
-
$4.00
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q4 2019
85 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q4 2019.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.4M shares
of 237M outstanding shares and own 13.7% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (11.5M shares), Consonance Capital Management LP (5.17M shares), BlackRock Inc. (3.97M shares), VANGUARD GROUP INC (2.31M shares), Schonfeld Strategic Advisors LLC (1.24M shares), STATE STREET CORP (843K shares), GEODE CAPITAL MANAGEMENT, LLC (717K shares), 683 Capital Management, LLC (700K shares), NORTHERN TRUST CORP (649K shares), and MORGENS WATERFALL VINTIADIS & CO INC (600K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.